Skip to content

Clinical trials

Phase 2 Primary Myelofibrosis trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Phase: Phase 2 Country / region: Belgium Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20151
20171
20182
20201
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting2
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation2
European Organisation for Research and Treatment of Cancer - EORTC1
Geron Corporation1
GlaxoSmithKline1
Karyopharm Therapeutics Inc1
Novartis Pharmaceuticals1
Stichting Hemato-Oncologie voor Volwassenen Nederland1
Telios Pharma, Inc.1
Universitaire Ziekenhuizen KU Leuven1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis10
Myeloproliferative Disorders2
Neoplasms2
Polycythemia Vera2
Anemia1
Ataxia Telangiectasia1
Blast Crisis1
Breast Neoplasms1
Bronchiolitis Obliterans1
Bronchiolitis Obliterans Syndrome1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.